The Trump administration is reportedly considering a proposal to charge patent holders a fee based on the value of their patents, potentially ranging from 1% to 5%. Experts have raised serious concerns, arguing that determining patent value is highly complex and subjective, and such a fee could discourage innovation, especially among small companies.
Commerce Department officials are discussing charging patent holders 1% to 5% of their overall patent value, a shift that could dramatically increase fees
View referenced article
Author(s)
Related Insights
September 23, 2026
Foley Viewpoints
FDA Medical Devices: Important Regulatory Considerations for Companies Seeking to Enter the U.S. Market
The medical device market in the U.S. is very large and attractive to many companies who are located outside of the U.S. Entering the U.S. medical device market requires a comprehensive, integrated strategy that goes beyond U.S. Food and Drug Administration (FDA) product clearance or approval — an effective market strategy must address key regulatory, quality, reimbursement, and commercial considerations.
September 22, 2026
Labor & Employment Law Perspectives
Risk Considerations As EEOC Moves To Ax Data Reports
On July 23, the U.S. Equal Employment Opportunity Commission published a proposed rule to rescind regulations requiring EEO-1 Component 1 reports and other workforce demographic reports and related recordkeeping.[1]
September 21, 2026
Innovative Technology Insights
Can Patent Filings Help Physical AI Companies Raise Capital?
For autonomous systems and physical AI companies, patent cadence can be part of the fundraising story when it maps to defensible shipped technology. This article examines the latest data on patent-funding correlation and translates it from the AV sector to the broader physical AI market.